ALOXE3 Antibody

The leukotrienes constitute a group of arachidonic acid-derived compounds with biologic activities suggesting important roles in inflammation and immediate hypersensitivity. These compounds are catabolized, in part, by lipoxygenases. Epidermis-type lipoxygenases, a distinct subclass within the multigene family of mammalian lipoxygenases, are novel isoenzymes isolated from human and mouse skin including human ALOX15B (MIM 603697), human and mouse ALOX12B (MIM 603741), mouse 8S-LOX, and mouse e-LOX-3.[supplied by OMIM]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: IF/IHC.

Showing Publications 1 - 2 of 2.

Publications using NBP1-32533	Applications	Species
Yang X, Liu J, Wang C et al. miR-18a promotes glioblastoma development by down-regulating ALOXE3-mediated ferroptotic and anti-migration activities Oncogenesis 2021-02-12 [PMID: 33579899] (IF/IHC, Human)	IF/IHC	Human
Sasaki K, Akiyama M, Yanagi T et al. CYP4F22 is highly expressed at the site and timing of onset of keratinization during skin development. J Dermatol Sci. 2011-12-13 [PMID: 22209317]

Array NBP1-32533

• ALOXE3 Antibodies
• ALOXE3 ELISA Kits
• ALOXE3 Lysate
• ALOXE3 Proteins